Clinical investigation of acute myocardial infarction according to age subsets

Wang,Jianwei; Li,Li; Ma,Ning; Zhang,Xiaohui; Qiao,Yanyan; Fang,Guangjie; Li,Guoping; Zhong,Tao

doi:10.3892/etm.2020.9248

Clinical investigation of acute myocardial infarction according to age subsets

Authors:
- Jianwei Wang
- Li Li
- Ning Ma
- Xiaohui Zhang
- Yanyan Qiao
- Guangjie Fang
- Guoping Li
- Tao Zhong
View Affiliations

Affiliations: ECG Room, Weifang Maternal and Child Health Hospital, Weifang, Shandong 261000, P.R. China, ECG Room, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China, ECG Room, Shengli Oilfield Central Hospital, Dongying, Shandong 257034, P.R. China, ECG Room, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong 271000, P.R. China, ECG Room, Weihai Municipal Hospital, Weihai, Shandong 234200, P.R. China, ECG Room, Tai'an Traditional Chinese Medicine Hospital, Tai'an, Shandong 271000, P.R. China, ECG Room, Dongying People's Hospital, Dongying, Shandong 257091, P.R. China, ECG Room, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: September 21, 2020 https://doi.org/10.3892/etm.2020.9248
Article Number: 120

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A growing number of ‘Young’ patients less than 40 years of age are being hospitalized with a diagnosis of acute myocardial infarction (AMI) due to increased prevalence of risk factors for atherosclerosis. The aim of this study was to compare clinical characteristics and performances of AMI between young and elderly patients. We conducted a retrospective study to compare AMI in young patients and elder patients. Based on the medical record databases in our hospital, we enrolled 114 ‘young’ AMI patients (age ≤42 years) and 179 ‘elder’ AMI patients (≥60 years), and then collected and analyzed their demographic information, clinical performances, and coronary angiography results. In the young AMI group, the proportion of male patients was higher than that in the elder AMI group (94.7 vs. 64.2%, P<0.05). Compared with the elder AMI patients, young patients had higher rates of smoking history and positive family medical history, but lower rates of hypertension and diabetes. Elder patients with AMI were more likely to develop various clinical performances, and multiple‑branch lesions; however, young AMI patients had relatively fewer symptoms, and the tissue lesions were more limited. The clinical profiles of AMI in young patients were different from that in elder AMI patients. Specific interventions should be carried out to prevent and control the prevalence of AMI in the young population.

View Figures

View References

1	Anderson JL and Morrow DA: Acute myocardial infarction. N Engl J Med. 376:2053–2064. 2017.PubMed/NCBI View Article : Google Scholar
2	Longjian L, Ling A and Xinglong Li: Analysis of death cause in the total population in Mentougou district of Beijing from 2006 to 2015. Xian Dai Yu Fang Yi Xue. 44:1823–1826. 2017.
3	Randall SM, Zilkens R, Duke JM and Boyd JH: Western Australia population trends in the incidence of acute myocardial infarction between 1993 and 2012. Int J Cardiol. 222:678–682. 2016.PubMed/NCBI View Article : Google Scholar
4	Schmidt M, Jacobsen JB, Lash TL, Bøtker HE and Sørensen HT: 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: A Danish nationwide cohort study. BMJ. 344(e356)2012.PubMed/NCBI View Article : Google Scholar
5	Dégano IR, Salomaa V, Veronesi G, Ferriéres J, Kirchberger I, Laks T, Havulinna AS, Ruidavets JB, Ferrario MM, Meisinger C, et al: Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart. 101:1413–1421. 2015.PubMed/NCBI View Article : Google Scholar
6	Wang DZ, Shen CF, Zhang Y, Zhang H, Song GD, Li W, Xue XD, Xu ZL, Zhang S and Jiang GH: Fifteen-year trend in incidence of acute myocardial infarction in Tianjin of China. Zhonghua Xin Xue Guan Bing Za Zhi. 45:154–159. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
7	Hernandez-Suarez DF, Osterman-Pla AD, Carrasquillo O, Aranda J, Baez S, Lopez M and Garcia-Rivera EJ: Epidemiological profile of hispanics admitted with acute myocardial infarction in Puerto Rico: The Experience of 2007, 2009 and 2011. J Clin Med Res. 9:528–533. 2017.PubMed/NCBI View Article : Google Scholar
8	Guo X, Li Z, Vittinghoff E, Sun Y and Pletcher MJ: Trends in rate of acute myocardial infarction among patients aged <30 years. Nat Rev Cardiol. 15(119)2018.PubMed/NCBI View Article : Google Scholar
9	Liu Y, Han T, Gao M, Wang J, Liu F, Zhou S and Chen Y: Clinical characteristics and prognosis of acute myocardial infarction in young smokers and non-smokers (≤45 years): A systematic review and meta-analysis. Oncotarget. 46:81195–81203. 2017.PubMed/NCBI View Article : Google Scholar
10	Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S and Afonso L: Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 58:1025–1033. 2011.PubMed/NCBI View Article : Google Scholar
11	Sailam V, Karalis DG, Agarwal A, Alani F, Galardi S, Covalesky V and Athanassious C: Prevalence of emerging cardiovascular risk factors in younger individuals with a family history of premature coronary heart disease and low Framingham risk score. Clin Cardiol. 31:542–545. 2008.PubMed/NCBI View Article : Google Scholar
12	Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, et al: Cardiovascular disease and risk factors in Asia: A selected review. Circulation. 118:2702–2709. 2008.PubMed/NCBI View Article : Google Scholar
13	Matsis K, Holley A, Al-Sinan A, Matsis P, Larsen PD and Harding SA: Differing clinical characteristics between young and older patients presenting with myocardial infarction. Heart Lung Circ. 26:566–571. 2017.PubMed/NCBI View Article : Google Scholar
14	Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Pettinger MB, et al: Estrogen therapy and coronary-artery calcification. N Engl J Med. 356:2591–2602. 2007.PubMed/NCBI View Article : Google Scholar
15	Sidney S, Petitti DB and Quesenberry CP Jr: Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med. 127:501–508. 1997.PubMed/NCBI View Article : Google Scholar
16	Ebrahim S, Taylor F, Ward K, Beswick A, Burke M and Davey Smith G: Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev: Jan 19, 2011 (Epub ahead of print). doi: 10.1002/14651858.CD001561.pub3.
17	Lakier JB: Smoking and cardiovascular disease. Am J Med. 93 (Suppl 1):S8–S12. 1992.PubMed/NCBI View Article : Google Scholar
18	Cavusoglu Y, Timuralp B, Us T, Akgün Y, Kudaiberdieva G, Gorenek B, Unalir A, Goktekin O and Ata N: Cigarette smoking increases plasma concentrations of vascular cell adhesion molecule-1 in patients with coronary artery disease. Angiology. 55:397–402. 2004.PubMed/NCBI View Article : Google Scholar
19	Yan S, Xiaopeng Z, Xudong J, Wenzhong Z, Wei W, Wenming C, Xin Z and Ning L: Potential mechanisms of oxidative damage mechanisms by smoking. Teratog Carcinog Mutagen. 21:50–53. 2009.PubMed/NCBI View Article : Google Scholar
20	Maosen W, Shengfeng W and Zitian Z: Clinical characteristics and treatment of old acute myocardial infarction patients. Contemp Med. 17:56–57. 2011.
21	The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 251:365–374. 1984.
22	Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 361:1149–1158. 2003.PubMed/NCBI View Article : Google Scholar
23	Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al: Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 366:1267–1278. 2005.PubMed/NCBI View Article : Google Scholar
24	Wenlin R, Dayi H, Jianjun P, et al: Clinical analysis of percutaneous coronary intervention in young AMI patients. Beijing Med J. 26:423–424. 2004.
25	Xuegang Y and Chuanrong C: Analysis of clinical characteristics and CAG results between old and young AMI patients. J Clin Cardiol. 13:281–365. 1997.